These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 21904456)

  • 1. Development of small interfering RNA delivery system using PEI-PEG-APRPG polymer for antiangiogenic vascular endothelial growth factor tumor-targeted therapy.
    Lu ZX; Liu LT; Qi XR
    Int J Nanomedicine; 2011; 6():1661-73. PubMed ID: 21904456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
    Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
    J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced cancer therapy by integrative antitumor actions via systemic administration of miR-499.
    Ando H; Asai T; Koide H; Okamoto A; Maeda N; Tomita K; Dewa T; Minamino T; Oku N
    J Control Release; 2014 May; 181():32-9. PubMed ID: 24593893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble Flt-1 gene delivery using PEI-g-PEG-RGD conjugate for anti-angiogenesis.
    Kim WJ; Yockman JW; Lee M; Jeong JH; Kim YH; Kim SW
    J Control Release; 2005 Aug; 106(1-2):224-34. PubMed ID: 15970348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA.
    Li JM; Wang YY; Zhang W; Su H; Ji LN; Mao ZW
    Int J Nanomedicine; 2013; 8():2101-17. PubMed ID: 23766646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient and Tumor Targeted siRNA Delivery by Polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate (PEI-PCL-PEG-Fol).
    Liu L; Zheng M; Librizzi D; Renette T; Merkel OM; Kissel T
    Mol Pharm; 2016 Jan; 13(1):134-43. PubMed ID: 26641134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer cell-specific VEGF siRNA delivery system using cell targeting peptide conjugated polyplexes.
    Kim SH; Lee SH; Tian H; Chen X; Park TG
    J Drug Target; 2009 May; 17(4):311-7. PubMed ID: 19242850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific cell targeting with APRPG conjugated PEG-PLGA nanoparticles for treating ovarian cancer.
    Wang Y; Liu P; Duan Y; Yin X; Wang Q; Liu X; Wang X; Zhou J; Wang W; Qiu L; Di W
    Biomaterials; 2014 Jan; 35(3):983-92. PubMed ID: 24176193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective delivery of an angiogenesis inhibitor by neovessel-targeted liposomes.
    Katanasaka Y; Ida T; Asai T; Maeda N; Oku N
    Int J Pharm; 2008 Aug; 360(1-2):219-24. PubMed ID: 18565703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEI-g-PEG-RGD/small interference RNA polyplex-mediated silencing of vascular endothelial growth factor receptor and its potential as an anti-angiogenic tumor therapeutic strategy.
    Kim J; Kim SW; Kim WJ
    Oligonucleotides; 2011; 21(2):101-7. PubMed ID: 21375397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes.
    Jin M; Jin G; Kang L; Chen L; Gao Z; Huang W
    Int J Nanomedicine; 2018; 13():2405-2426. PubMed ID: 29719390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of APRPG-modified angiogenic vessel targeting micelles for anticancer therapy.
    Guo P; Song S; Li Z; Tian Y; Zheng J; Yang X; Pan W
    Int J Pharm; 2015; 486(1-2):356-66. PubMed ID: 25840274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer.
    Kim SH; Jeong JH; Lee SH; Kim SW; Park TG
    J Control Release; 2008 Jul; 129(2):107-16. PubMed ID: 18486981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The investigation of polymer-siRNA nanoparticle for gene therapy of gastric cancer in vitro.
    Wu Y; Wang W; Chen Y; Huang K; Shuai X; Chen Q; Li X; Lian G
    Int J Nanomedicine; 2010 Mar; 5():129-36. PubMed ID: 20309399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEG conjugated VEGF siRNA for anti-angiogenic gene therapy.
    Kim SH; Jeong JH; Lee SH; Kim SW; Park TG
    J Control Release; 2006 Nov; 116(2):123-9. PubMed ID: 16831481
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Wan X; Sun R; Bao Y; Zhang C; Wu Y; Gong Y
    Mol Pharm; 2021 Nov; 18(11):3990-3998. PubMed ID: 34591491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vivo Antitumor Activity of Folate-Conjugated Cholic Acid-Polyethylenimine Micelles for the Codelivery of Doxorubicin and siRNA to Colorectal Adenocarcinomas.
    Amjad MW; Amin MC; Katas H; Butt AM; Kesharwani P; Iyer AK
    Mol Pharm; 2015 Dec; 12(12):4247-58. PubMed ID: 26567518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle.
    Schiffelers RM; Ansari A; Xu J; Zhou Q; Tang Q; Storm G; Molema G; Lu PY; Scaria PV; Woodle MC
    Nucleic Acids Res; 2004 Nov; 32(19):e149. PubMed ID: 15520458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of polyethylene glycol-grafted polyethylenimine and superparamagnetic iron oxide nanoparticles (PEG-g-PEI-SPION) as an MRI-visible vector for siRNA delivery in gastric cancer in vitro and in vivo.
    Chen Y; Lian G; Liao C; Wang W; Zeng L; Qian C; Huang K; Shuai X
    J Gastroenterol; 2013 Jul; 48(7):809-21. PubMed ID: 23179610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly effective antiangiogenesis via magnetic mesoporous silica-based siRNA vehicle targeting the VEGF gene for orthotopic ovarian cancer therapy.
    Chen Y; Wang X; Liu T; Zhang DS; Wang Y; Gu H; Di W
    Int J Nanomedicine; 2015; 10():2579-94. PubMed ID: 25848273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.